Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy
- 30 November 2000
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 85 (5), 398-406
- https://doi.org/10.1016/s1081-1206(10)62555-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthmaClinical Therapeutics, 1999
- The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthmaClinical and Experimental Allergy, 1999
- Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthmaJournal of Allergy and Clinical Immunology, 1997
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Glucocorticosteroids Inhibit Leukotriene ProductionAnnals of Allergy, Asthma & Immunology, 1997
- Inhaled steroids and the risk of hospitalization for asthmaPublished by American Medical Association (AMA) ,1997
- Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4 receptor antagonistCanadian Journal of Physiology and Pharmacology, 1995
- Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthmaJournal of Allergy and Clinical Immunology, 1994
- Increased nitric oxide in exhaled air of asthmatic patientsThe Lancet, 1994
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994